End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.52 CNY | -0.10% | -2.36% | -25.62% |
Apr. 19 | Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 29 | Teyi Pharmaceutical Group Co.,Ltd Approves the Cash Dividend for 2023 | CI |
Sales 2024 * | 1.16B 161M | Sales 2025 * | 1.38B 190M | Capitalization | 4.86B 672M |
---|---|---|---|---|---|
Net income 2024 * | 285M 39.38M | Net income 2025 * | 361M 49.88M | EV / Sales 2024 * | 4.17 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.53 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
13.5
x | Employees | 1,243 |
Yield 2024 * |
4.43% | Yield 2025 * |
3.97% | Free-Float | 0% |
1 day | -0.10% | ||
1 week | -2.36% | ||
Current month | -0.94% | ||
1 month | -17.11% | ||
3 months | -7.83% | ||
6 months | -22.24% | ||
Current year | -25.62% |
Managers | Title | Age | Since |
---|---|---|---|
Dan Qing Xu
CEO | Chief Executive Officer | 55 | 09-06-14 |
Xi Liang Chen
DFI | Director of Finance/CFO | 52 | 09-06-14 |
Wei Cheng Wu
BRD | Director/Board Member | 55 | 18-11-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Qing Xu
CEO | Chief Executive Officer | 55 | 09-06-14 |
Song Qing Xu
BRD | Director/Board Member | 54 | 09-06-14 |
Xi Liang Chen
DFI | Director of Finance/CFO | 52 | 09-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 9.52 | -0.10% | 7,177,369 |
24-05-17 | 9.53 | +0.11% | 8,031,051 |
24-05-16 | 9.52 | -0.52% | 7,934,702 |
24-05-15 | 9.57 | -2.05% | 9,941,663 |
24-05-14 | 9.77 | +0.21% | 10,057,400 |
End-of-day quote Shenzhen S.E., May 19, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.62% | 672M | |
+34.35% | 705B | |
+30.55% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.00% | 238B | |
-3.15% | 210B | |
+10.50% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 002728 Stock